EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 371 filers reported holding EXELIXIS INC in Q3 2020. The put-call ratio across all filers is 2.74 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2,235,339 | -37.2% | 99,481 | -33.7% | 0.01% | -38.5% |
| Q1 2024 | $3,559,500 | +30.2% | 150,000 | +31.6% | 0.01% | +18.2% |
| Q4 2023 | $2,734,884 | -27.6% | 114,001 | -34.1% | 0.01% | -26.7% |
| Q3 2023 | $3,777,887 | +9.4% | 172,901 | -4.3% | 0.02% | +7.1% |
| Q2 2023 | $3,452,719 | -29.8% | 180,676 | -28.7% | 0.01% | -36.4% |
| Q1 2023 | $4,921,871 | +113490.4% | 253,574 | -6.1% | 0.02% | +10.0% |
| Q4 2022 | $4,333 | +2.3% | 270,129 | 0.0% | 0.02% | -4.8% |
| Q3 2022 | $4,236 | -99.9% | 270,129 | -30.7% | 0.02% | -44.7% |
| Q2 2022 | $8,116,000 | +5.4% | 389,804 | +14.7% | 0.04% | +26.7% |
| Q1 2022 | $7,703,000 | +201.4% | 339,804 | +143.1% | 0.03% | +233.3% |
| Q4 2021 | $2,556,000 | +51.4% | 139,804 | +75.2% | 0.01% | +28.6% |
| Q3 2021 | $1,688,000 | -52.1% | 79,804 | -58.8% | 0.01% | -46.2% |
| Q2 2021 | $3,525,000 | -19.4% | 193,493 | 0.0% | 0.01% | -27.8% |
| Q1 2021 | $4,371,000 | +56.1% | 193,493 | +38.7% | 0.02% | +50.0% |
| Q4 2020 | $2,800,000 | -53.8% | 139,517 | -43.7% | 0.01% | -57.1% |
| Q3 2020 | $6,058,000 | +12.0% | 247,791 | +8.8% | 0.03% | +7.7% |
| Q2 2020 | $5,408,000 | +28.6% | 227,791 | -6.7% | 0.03% | +8.3% |
| Q1 2020 | $4,205,000 | +68.9% | 244,173 | +72.8% | 0.02% | +118.2% |
| Q4 2019 | $2,490,000 | -46.8% | 141,339 | -46.6% | 0.01% | -50.0% |
| Q3 2019 | $4,680,000 | +7.6% | 264,639 | +30.0% | 0.02% | +4.8% |
| Q2 2019 | $4,350,000 | +79.2% | 203,537 | +99.5% | 0.02% | +75.0% |
| Q1 2019 | $2,428,000 | +21.0% | 102,028 | 0.0% | 0.01% | +9.1% |
| Q4 2018 | $2,007,000 | +270.3% | 102,028 | +233.7% | 0.01% | +266.7% |
| Q3 2018 | $542,000 | – | 30,576 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $320,572,000 | 64.48% |
| Sargent Investment Group, LLC | 432,125 | $9,235,000 | 4.22% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 443,534 | $9,483,000 | 3.52% |
| Bellevue Group AG | 3,878,800 | $82,890,000 | 1.42% |
| CAPITAL MANAGEMENT CORP /VA | 237,855 | $5,083,000 | 1.40% |
| Orbimed Advisors | 3,912,900 | $83,619,000 | 1.30% |
| Portolan Capital Management | 540,590 | $11,552,000 | 1.24% |
| TEALWOOD ASSET MANAGEMENT INC | 139,347 | $2,978,000 | 1.21% |
| Signition LP | 84,120 | $1,798,000,000 | 1.18% |
| Penn Capital Management Company, LLC | 529,630 | $11,318,000 | 1.12% |